Potentially dilutive securities not included in the calculation of diluted net loss per share, because to do so would be anti-dilutive, are as follows (in common stock equivalent shares): | | | June 30, | | | Potentially Dilutive Securities Listing: | | 2026 | | | 2025 | | | Options to purchase common stock | | | 5 | | | | 18 | | | Warrants for common stock | | | 152 | | | | 165 | | | Class A warrants for common stock | | | 77 | | | | 77 | | | Class B warrants for common stock | | | 2 | | | | 2 | | | January 2024 warrants for common stock | | | 1,682 | | | | 1,682 | | | January 2024 placement agent warrants for common stock | | | 117 | | | | 117 | | | Class C warrants for common stock | | | 71,873 | | | | 71,873 | | | Class E warrants for common stock | | | 271,277 | | | | 271,277 | | | Series F warrants for common stock | | | 1,125,000 | | | | - | | | Series F placement agent warrants for common stock | | | 45,000 | | | | - | | | Series G warrants for common stock | | | 3,655,917 | | | | - | | | Series G placement agent warrants for common stock | | | 255,914 | | | | - | | | Series H warrants for common stock | | | 3,655,917 | | | | - | |
|